Literature DB >> 585371

[In vitro activity of mezlocillin, azlocillin and carbenicillin against bacteroidaceae with particular reference to bacteroides fragilis (author's transl)].

H Werner, C Krassemann, J Ungerechts, H J Schmitz.   

Abstract

The in vitro susceptibility of approximately 90 Bacteroidaceae strains to the the new broad-spectrum penicillins mezlocillin and azlocillin was determined by tube dilution tests and compared to susceptibility to carbenicillin. Bacteroides fragilis and Bacteroides thetaiotaomicron predominated among the strains tested. These strains are particularly important as pathogens and are known to produce beta-lactamase. At concentrations of 16 microng/ml or less, mezlocilin inhibited 81% of the Bacteroides cultures, and at 32 microng/ml 96% of the cultures. The amount of Bacteroides strains inhibited by 16 and 32 microng/ml of azlocillin was 67% and 93% respectively. Similar results were obtained with carbenicillin, concentrations of 32, 64 and 256 microng/ml inhibiting 55%, 87% and 94% of the strains respectively. Mezlocillin and azlocillin did not appear to be any more effective than carbenicillin against Sphaerophorus strains. Statistical analysis of the relationship between minimal inhibiting concentration and inhibition zone diameter showed that the susceptibility of Bacteroidaceae to mezlocillin, azlocillin and carbenicillin cannot be determined with sufficient accuracy by a standardized agar diffusion test.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 585371     DOI: 10.1007/bf01639104

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  [A new butyric acid-producing bacteroides species: B. splanchnicus n. sp. (author's transl)].

Authors:  H Werner; G Rintelen; H Kunstek-Santos
Journal:  Zentralbl Bakteriol Orig A       Date:  1975

2.  Carbenicillin in the treatment of infections involving anaerobic bacteria.

Authors:  R M Swenson; B Lorber
Journal:  Antimicrob Agents Chemother       Date:  1976-06       Impact factor: 5.191

3.  Characterisation of a -lactamase obtained from a strain of Bacteroides fragilis resistant to -lactam antibiotics.

Authors:  J D Anderson; R B Sykes
Journal:  J Med Microbiol       Date:  1973-05       Impact factor: 2.472

Review 4.  [Infections caused by gramnegative anaerobic bacteria].

Authors:  H Werner
Journal:  Med Klin       Date:  1975-11-21

5.  Differentiation and medical importance of saccharolytic intestinal Bacteroides.

Authors:  H Werner
Journal:  Arzneimittelforschung       Date:  1974-03

6.  [Pharmacokinetics of azlocillin, a new semisynthetic, wide-spectrum antibiotic (author's transl)].

Authors:  K Wirth; M Schomerus; J H Hengstmann
Journal:  Infection       Date:  1976       Impact factor: 3.553

7.  Susceptibility of Anaerobic bacteria to carbenicillin, cefoxitin, and related drugs.

Authors:  V L Sutter; S M Finegold
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

8.  Beta-lactamase activity in anaerobic bacteria.

Authors:  A E Weinrich; V E Del bene
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

9.  [Susceptibility to Thiamphenicol and Chloramphenicol of Anaerobic Bacteria (author's transl)].

Authors:  H Werner; C Krasemann; W Gorniak; A Hermann; J Ungerechts
Journal:  Zentralbl Bakteriol Orig A       Date:  1977

10.  A comparative study of 55 Sphaerophorus strains. Differentiation of 3 species: Sphaerophorus necrophorus, Sph, varius, and Sph. freundii.

Authors:  H Werner
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

  10 in total
  7 in total

1.  [Azlocillin--a new penicillin against Pseudomonas aeruginosa and other gram-negative bacteria].

Authors:  H B König; K G Metzger; R P Mürmann; H A Offe; P Schacht; W Schröck
Journal:  Infection       Date:  1977       Impact factor: 3.553

2.  [Systemic mezlocillin prophylaxis in elective colon surgery].

Authors:  M Wenzel; M Walden; M Heinrich; B Neuhaus
Journal:  Infection       Date:  1982       Impact factor: 3.553

3.  [Concentrations of mezlocillin in cerebrospinal fluid in vira meningitis (author's transl)].

Authors:  H G Hoffmann; D Förster; I Schoen
Journal:  Infection       Date:  1980       Impact factor: 3.553

4.  Pharmacokinetics of mezlocillin in healthy volunteers.

Authors:  T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

5.  Pharmacokinetics of azlocillin in subjects with normal and impaired renal function.

Authors:  A Leroy; G Humbert; M Godin; J P Fillastre
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

6.  [In vitro effect of acylureido penicillins and mezlocillin on anaerobic sporeless gram-negative rods of genus Bacteroides].

Authors:  C Höhne
Journal:  Infection       Date:  1982       Impact factor: 3.553

7.  Mezlocillin dose dependent elimination kinetics in renal impairment.

Authors:  G R Aronoff; R S Sloan; R A Stanish; N S Fineberg
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.